XML 29 R3.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Net sales $ 1,839,686,000 $ 1,953,313,000 $ 1,943,585,000
Cost of goods sold (excluding amortization expense - See Note 15) 1,153,656,000 1,247,669,000 1,330,931,000
Gross profit 686,030,000 705,644,000 612,654,000
Selling, general and administrative expenses 484,794,000 483,561,000 464,187,000
Impairment charges 0 0 93,000,000
Restructuring and related charges, net 6,530,000 7,588,000 3,163,000
Operating income 194,706,000 214,495,000 52,304,000
Other income (expense), net 1,354,000 (10,672,000) (12,607,000)
Interest expense, net (41,002,000) (50,699,000) (32,579,000)
Income before taxes and equity in net income of associated companies 155,058,000 153,124,000 7,118,000
Taxes on income before equity in net income of associated companies 49,300,000 55,585,000 24,925,000
Income (loss) before equity in net income of associated companies 105,758,000 97,539,000 (17,807,000)
Equity in net income of associated companies 10,971,000 15,333,000 1,965,000
Net income (loss) 116,729,000 112,872,000 (15,842,000)
Less: Net income attributable to noncontrolling interest 85,000 124,000 89,000
Net income (loss) attributable to Quaker Chemical Corporation $ 116,644,000 $ 112,748,000 $ (15,931,000)
Per share data:      
Net income (loss) attributable to Quaker Chemical Corporation common shareholders – basic (in dollars per share) $ 6.51 $ 6.27 $ (0.89)
Net income (loss) attributable to Quaker Chemical Corporation common shareholders – diluted (in dollars per share) $ 6.51 $ 6.26 $ (0.89)